Prostate cancer study tracks how hormone drugs impact daily life in seniors
NCT ID NCT03516110
First seen Jan 27, 2026 · Last updated May 14, 2026 · Updated 16 times
Summary
This study followed 831 men aged 60 and older with prostate cancer who were starting hormone therapy (GnRH agonists). Researchers tracked changes in quality of life over six months, comparing different age groups. The goal was to understand how this common treatment affects older patients' well-being, not to test a new drug or cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ipsen Central Contact
Paris, France
Conditions
Explore the condition pages connected to this study.